Ltbp2tm2b(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Ltbp2tm2b(KOMP)Wtsi |
Name: |
latent transforming growth factor beta binding protein 2; targeted mutation 2b, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5635878 |
Gene: |
Ltbp2 Location: Chr12:84829986-84923306 bp, - strand Genetic Position: Chr12, 39.39 cM, cytoband D
|
Alliance: |
Ltbp2tm2b(KOMP)Wtsi page
|
IMPC: |
Ltbp2 gene page |
|
Mutant Cell Line: |
EPD0865_1_B07 |
Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Pgk_P
|
|
|
Mutation details: The L1L2_Pgk_P cassette was inserted at position 84875726 of Chromosome 12 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by neomycin resistance gene under the control of the PGK promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of the targeted exon(s) at position 84876563. The critical exon(s) were thus flanked by loxP sites and subsequent Cre-mediated excision deleted the critical sequence and the neomycin selection cassette yielding this knockout reporter allele. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:148605, J:173534, J:188991)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:188991 The Jackson Laboratory, Alleles produced for the KOMP project by The Jackson Laboratory. MGI Direct Data Submission. 2012; |
All: |
5 reference(s) |
|